FY26C3BP6 - advancing the development of external controls for invasive fungal i
Active Definitive Contract Awarded Last action
- Contract number
- 75F40126C00197
- Awardee
-
Carelane LLC UEI WVBLJFGMAU46
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $293,829
Award facts
- Contract value 100% obligated
- $293,829.00 Current and potential, with all options
- Completion date 2% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10025, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $293,829 definitive contract to Carelane LLC for advancing the development of external controls for invasive fungal infections on September 30, 2026.
Place of performance is New York, NY. The contract runs through September 29, 2028 on a firm fixed-price basis.
Quick answers
Who was awarded contract 75F40126C00197?
75F40126C00197 was awarded to Carelane LLC by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.
How much is contract 75F40126C00197 worth?
The government has obligated $293,829 on 75F40126C00197.
Was contract 75F40126C00197 competed?
The extent of competition for 75F40126C00197 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award